Key result
Catheter ablation for paroxysmal atrial fibrillation using the Thermocool Smarttouch Catheter resulted in average 1-year per-patient savings of US$1488 vs SF and US$4494 vs CB.
Why the study?
To compare the 1-year costs of three catheter ablation technologies for the treatment of paroxysmal atrial fibrillation.
Does the Thermocool Smarttouch Catheter reduce 1-year hospital costs compared to Thermocool SF or Arctic Front Advance Cryoballoon in patients with paroxysmal atrial fibrillation?
Does the Thermocool Smarttouch Catheter reduce 1-year hospital costs compared to Thermocool SF or Arctic Front Advance Cryoballoon in patients with paroxysmal atrial fibrillation?
The use of the Thermocool Smarttouch Catheter for PAF ablation is associated with lower 1-year expected hospital visit costs compared to Thermocool SF or Arctic Front Advance Cryoballoon.
Answers are grounded in this paper and cite their sources.
Supports cost reduction via contact-force sensing ablation in paroxysmal AF; extends RCT economic evidence versus SF and CB.
Aim: Compare the 1-year costs of three catheter ablation technologies for the treatment of paroxysmal atrial fibrillation (PAF). Materials & methods: A decision tree model was developed to estimate 1-year hospital costs associated with an index and potential repeat PAF ablation procedure using the Thermocool ® Smarttouch ® Catheter (ST), Thermocool SF Catheter (SF) or Arctic Front Advance Cryoballoon (CB). Model parameters were estimated using the results of two recently published studies. Results: The ST resulted in average per-patient savings for combined inpatient and outpatient populations of US$1488 and US$4494 compared with SF and CB, respectively. These cost savings were greater in the inpatient setting. Conclusion: The 1-year expected hospital visit costs for PAF ablation were lower with ST than with SF or CB.
No takes yet. Share an insight, caveat, or question.
Osorio et al. (2019) studied paroxysmal atrial fibrillation (PAF). Thermocool Smarttouch Catheter (ST) vs. Thermocool SF Catheter (SF) or Arctic Front Advance Cryoballoon (CB) was evaluated on 1-year hospital costs associated with an index and potential repeat PAF ablation procedure. Catheter ablation for paroxysmal atrial fibrillation using the Thermocool Smarttouch Catheter resulted in average 1-year per-patient savings of US$1488 vs SF and US$4494 vs CB.
Synapse has enriched 10 related papers. Consider them for comparative context: